Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 6973 | 24.47 |
09:34 ET | 4257 | 24.5 |
09:36 ET | 8990 | 24.46 |
09:38 ET | 2703 | 24.39 |
09:39 ET | 4000 | 24.28 |
09:41 ET | 2401 | 24.34 |
09:43 ET | 1691 | 24.295 |
09:45 ET | 1510 | 24.26 |
09:48 ET | 200 | 24.24 |
09:50 ET | 5080 | 24.26 |
09:52 ET | 1097 | 24.2559 |
09:54 ET | 4400 | 24.32 |
09:56 ET | 700 | 24.3 |
09:57 ET | 100 | 24.315 |
09:59 ET | 3036 | 24.31 |
10:01 ET | 1000 | 24.34 |
10:03 ET | 1001 | 24.31 |
10:06 ET | 3500 | 24.3 |
10:08 ET | 5952 | 24.295 |
10:10 ET | 2800 | 24.28 |
10:12 ET | 500 | 24.32 |
10:14 ET | 4522 | 24.32 |
10:15 ET | 2000 | 24.31 |
10:17 ET | 3900 | 24.36 |
10:19 ET | 1035 | 24.31 |
10:21 ET | 2300 | 24.22 |
10:24 ET | 807 | 24.24 |
10:26 ET | 2949 | 24.24 |
10:28 ET | 2912 | 24.26 |
10:30 ET | 500 | 24.245 |
10:32 ET | 2194 | 24.2 |
10:33 ET | 2314 | 24.23 |
10:35 ET | 500 | 24.24 |
10:37 ET | 1000 | 24.29 |
10:39 ET | 1992 | 24.3 |
10:42 ET | 2605 | 24.28 |
10:44 ET | 2170 | 24.26 |
10:46 ET | 793 | 24.26 |
10:48 ET | 2200 | 24.26 |
10:50 ET | 500 | 24.25 |
10:51 ET | 950 | 24.24 |
10:53 ET | 428 | 24.24 |
10:55 ET | 500 | 24.23 |
10:57 ET | 2651 | 24.205 |
11:00 ET | 1720 | 24.17 |
11:02 ET | 1561 | 24.18 |
11:04 ET | 1200 | 24.15 |
11:06 ET | 7920 | 24.13 |
11:08 ET | 918 | 24.13 |
11:09 ET | 1967 | 24.12 |
11:11 ET | 4090 | 24.09 |
11:13 ET | 4120 | 24.09 |
11:15 ET | 1064 | 24.1 |
11:18 ET | 600 | 24.11 |
11:20 ET | 1915 | 24.13 |
11:22 ET | 200 | 24.13 |
11:24 ET | 400 | 24.15 |
11:26 ET | 2833 | 24.13 |
11:27 ET | 2876 | 24.12 |
11:29 ET | 1244 | 24.14 |
11:33 ET | 900 | 24.13 |
11:36 ET | 2573 | 24.11 |
11:38 ET | 2400 | 24.07 |
11:40 ET | 768 | 24.07 |
11:42 ET | 2528 | 24.08 |
11:44 ET | 1800 | 24.045 |
11:45 ET | 2290 | 24.04 |
11:47 ET | 3397 | 24.04 |
11:49 ET | 918 | 24.04 |
11:51 ET | 4975 | 24.04 |
11:54 ET | 2000 | 24.05 |
11:56 ET | 1000 | 24.06 |
11:58 ET | 1321 | 24.08 |
12:00 ET | 300 | 24.08 |
12:02 ET | 2926 | 24.1 |
12:03 ET | 1096 | 24.08 |
12:09 ET | 3753 | 24.07 |
12:12 ET | 3498 | 24.045 |
12:14 ET | 400 | 24.05 |
12:16 ET | 2566 | 24.04 |
12:18 ET | 5156 | 24.06 |
12:20 ET | 2000 | 24.06 |
12:21 ET | 1787 | 24.06 |
12:23 ET | 2222 | 24.09 |
12:25 ET | 3500 | 24.1 |
12:27 ET | 1900 | 24.09 |
12:30 ET | 400 | 24.11 |
12:32 ET | 2100 | 24.11 |
12:34 ET | 7052 | 24.1 |
12:36 ET | 500 | 24.1 |
12:38 ET | 600 | 24.09 |
12:39 ET | 3350 | 24.105 |
12:41 ET | 1510 | 24.08 |
12:43 ET | 1000 | 24.07 |
12:45 ET | 700 | 24.08 |
12:48 ET | 1314 | 24.1 |
12:50 ET | 1632 | 24.12 |
12:52 ET | 500 | 24.12 |
12:54 ET | 2764 | 24.11 |
12:56 ET | 1600 | 24.12 |
12:57 ET | 1300 | 24.13 |
12:59 ET | 1300 | 24.13 |
01:01 ET | 1749 | 24.13 |
01:03 ET | 3232 | 24.12 |
01:06 ET | 1200 | 24.1 |
01:08 ET | 1036 | 24.13 |
01:10 ET | 1135 | 24.14 |
01:12 ET | 1400 | 24.145 |
01:14 ET | 1100 | 24.135 |
01:15 ET | 3656 | 24.14 |
01:17 ET | 500 | 24.135 |
01:19 ET | 1960 | 24.12 |
01:21 ET | 1600 | 24.085 |
01:24 ET | 1663 | 24.09 |
01:26 ET | 100 | 24.09 |
01:28 ET | 1300 | 24.08 |
01:30 ET | 1556 | 24.065 |
01:32 ET | 698 | 24.08 |
01:33 ET | 3432 | 24.045 |
01:35 ET | 1110 | 24.04 |
01:37 ET | 2933 | 24.05 |
01:39 ET | 900 | 24.06 |
01:42 ET | 2699 | 24.06 |
01:44 ET | 100 | 24.06 |
01:46 ET | 1493 | 24.08 |
01:48 ET | 803 | 24.09 |
01:50 ET | 1514 | 24.095 |
01:51 ET | 4439 | 24.08 |
01:53 ET | 574 | 24.08 |
01:55 ET | 690 | 24.09 |
01:57 ET | 700 | 24.1 |
02:00 ET | 1640 | 24.11 |
02:02 ET | 3485 | 24.11 |
02:04 ET | 8357 | 24.09 |
02:06 ET | 2530 | 24.08 |
02:08 ET | 600 | 24.08 |
02:09 ET | 9422 | 24.13 |
02:11 ET | 1758 | 24.11 |
02:13 ET | 8000 | 24.12 |
02:15 ET | 3789 | 24.13 |
02:18 ET | 1525 | 24.13 |
02:20 ET | 34718 | 24.14 |
02:22 ET | 9519 | 24.13 |
02:24 ET | 7845 | 24.1 |
02:26 ET | 1321 | 24.08 |
02:27 ET | 2500 | 24.09 |
02:29 ET | 8056 | 24.075 |
02:31 ET | 9116 | 24.09 |
02:33 ET | 4490 | 24.1 |
02:36 ET | 12002 | 24.09 |
02:38 ET | 3568 | 24.05 |
02:40 ET | 2096 | 24.03 |
02:42 ET | 1841 | 24.02 |
02:44 ET | 1908 | 24.03 |
02:45 ET | 1306 | 24.03 |
02:47 ET | 3980 | 24.04 |
02:49 ET | 8088 | 24.01 |
02:51 ET | 24381 | 24.045 |
02:54 ET | 3825 | 24.045 |
02:56 ET | 3355 | 24.025 |
02:58 ET | 3655 | 24.035 |
03:00 ET | 32936 | 24.06 |
03:02 ET | 6157 | 24.07 |
03:03 ET | 3489 | 24.02 |
03:05 ET | 4956 | 24.01 |
03:07 ET | 13321 | 24.02 |
03:09 ET | 6281 | 24.01 |
03:12 ET | 15901 | 24 |
03:14 ET | 1974 | 23.985 |
03:16 ET | 6001 | 23.945 |
03:18 ET | 5964 | 23.95 |
03:20 ET | 3308 | 23.96 |
03:21 ET | 6133 | 23.97 |
03:23 ET | 700 | 23.965 |
03:25 ET | 1800 | 23.975 |
03:27 ET | 1333 | 23.975 |
03:30 ET | 4860 | 23.99 |
03:32 ET | 6349 | 23.97 |
03:34 ET | 6103 | 23.96 |
03:36 ET | 7086 | 24 |
03:38 ET | 10851 | 23.975 |
03:39 ET | 9283 | 23.94 |
03:41 ET | 6402 | 23.93 |
03:43 ET | 8101 | 23.96 |
03:45 ET | 6220 | 23.945 |
03:48 ET | 6918 | 23.925 |
03:50 ET | 8811 | 23.92 |
03:52 ET | 96276 | 24.01 |
03:54 ET | 10731 | 23.97 |
03:56 ET | 48459 | 24.09 |
03:57 ET | 27018 | 24.08 |
03:59 ET | 44604 | 24.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.5B | 34.7x | -21.77% |
PTC Therapeutics Inc | 2.3B | -4.0x | --- |
P3 Health Partners Inc | 142.3M | -0.8x | --- |
Novavax Inc | 1.8B | -4.0x | --- |
Qiagen NV | 9.1B | 27.3x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.1x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.